Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO Immuno-Oncology 2022 | Addressing and overcoming limitations in cancer vaccines

Michael Nishimura, PhD, Loyola University Chicago, Chicago, IL, provides an overview of challenges associated with cancer vaccines in solid tumors. The immunosuppressive nature of the tumor microenvironment limits the efficacy of cancer vaccines, especially with the presence of neoantigens. Strategies including combining cancer vaccines with existing checkpoint inhibitors are needed to overcome the hostile environment. This interview took place at the ESMO Immuno-Oncology Congress 2022 in Geneva, Switzerland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.